Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Humana Inc. buy Argus

Start price
€445.70
12.12.23 / 50%
Target price
€510.29
12.12.24
Performance (%)
-35.47%
Price
€286.00
26.04.24
Summary
This prediction is currently active. The BUY prediction by Argus for Humana Inc. is performing very badly with a performance of -35.47%. Dividends of €1.62 are taken into consideration when calculating the performance. This prediction currently runs until 12.12.24. The prediction end date can be changed by Argus at any time. Argus has 50% into this prediction

Humana Inc. (Symbol: HUM) is a leading healthcare and wellness company headquartered in Louisville, Kentucky, specializing in offering a diversified range of health insurance, wellness programs, and managed care plans to individual, group, government, and military customers. With a strong commitment to providing personalized, affordable, and high-quality healthcare solutions, Humana emphasizes on simplifying access and meeting the evolving needs of its vast clientele through leveraging data analytics, technology, and innovation. As a publicly traded entity, Humana’s stock is listed on the New York Stock Exchange, and it forms part of the esteemed S&P 500 index, reflecting its significant impact and presence within the highly competitive healthcare sector.

Performance without dividends (%)
Name 1w 1m
Humana Inc. -7.173% -7.173%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Argus for this prediction

In the thread Humana Inc. diskutieren
Prediction Buy
Perf. (%) -35.47%
Target price 510.290
Change
Ends at 12.12.24

Humana Inc. (NYSE: HUM) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $550.00 price target on the stock.
Ratings data for HUM provided by MarketBeat